MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Sinovac Biotech Company Profile (NASDAQ:SVA)

Consensus Ratings for Sinovac Biotech (NASDAQ:SVA) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Sinovac Biotech (NASDAQ:SVA)
Show:
DateFirmActionRatingPrice TargetActions
8/15/2014AegisBoost Price TargetBuy$7.00 -> $10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/25/2014 forward)
Earnings History for Sinovac Biotech (NASDAQ:SVA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/12/2016        
5/26/2016Q116($0.01)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/5/2016Q415$0.01$22.95 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/11/2015Q315($0.02)($0.03)$27.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2015Q215($0.01)$0.04$15.70 million$18.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/15/2015Q115$0.02($0.04)$12.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/20/2015Q414$0.01$0.02$14.10 million$22.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/14/2014Q214$0.01($0.04)$17.20 million$12.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/19/2014Q4 13($0.01)$0.10$18.75 million$22.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2013Q3$0.04ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/15/2012Q312($0.03)($0.06)$12.35 million$14.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Sinovac Biotech (NASDAQ:SVA)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Sinovac Biotech (NASDAQ:SVA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Sinovac Biotech (NASDAQ:SVA)
No insider trades for this company have been tracked by MarketBeat.com

Latest Headlines for Sinovac Biotech (NASDAQ:SVA)
DateHeadline
05/30/16 04:56 PMSinovac Biotech Incorporated (NASDAQ:SVA) Sellers Covered 6.68% of Their Shorts - HNN - Sinovac Biotech Incorporated (NASDAQ:SVA) Sellers Covered 6.68% of Their ShortsHNNThe short interest to Sinovac Biotech Incorporated's float is 1.18%. The stock increased 0.16% or $0.01 on May 27, hitting $6.09. About 49,676 shares traded hands. Sinovac Biotech Ltd. (NASDAQ:SVA) has risen 15.12% since October 22, 2015 and is ...
05/28/16 07:15 AMSinovac Biotech's (SVA) Management on Q1 2016 Results - Earnings Call Transcript - Seeking Alpha - Sinovac Biotech's (SVA) Management on Q1 2016 Results - Earnings Call TranscriptSeeking AlphaGreetings and welcome to the Sinovac Biotech Ltd. first quarter 2016 earnings conference call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a ...Sinovac Biotech, Ltd. (NASDAQ:SVA) Updated Analyst CoverageRisers & FallersSinovac Biotech Narrows Q1 Adjusted Loss on Stronger Revenues (NASDAQ:SVA)Sonoran Weekly ReviewSinovac Biotech Ltd.: Sinovac Reports Unaudited First Quarter 2016 Financial R...The Wall Street Transcriptall 7 news articles »
05/27/16 05:11 PMSinovac Biotech's (SVA) Management on Q1 2016 Results - Earnings Call Transcript - Greetings and welcome to the Sinovac Biotech Ltd. first quarter 2016 earnings conference call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a ...
05/26/16 10:06 PMEARNINGS SUMMARY: Details of Sinovac Biotech Ltd. Q1 Earnings Report - Below are the earnings highlights for Sinovac Biotech Ltd. (SVA): -Earnings: -$1.40 million in Q1 vs. -$2.55 million in the same period last year. -EPS: -$0.01 in Q1 vs. -$0.03 in the same period last year. -Revenue: $10.95 million in Q1 vs. $9.21 million ...
05/26/16 08:17 PMSinovac Reports Unaudited First Quarter 2016 Financial R... - [at noodls] - BEIJING, May 26, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited first quarter ended March 31, 2016. First Quarter ...
05/26/16 05:09 PMSinovac posts 1Q profit -
05/26/16 05:00 PMSinovac Reports Unaudited First Quarter 2016 Financial Results - [PR Newswire] - BEIJING, May 26, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited first quarter ended March 31, 2016. First ...
05/26/16 06:07 AMQ1 2016 Sinovac Biotech Ltd Earnings Release - After Market Close -
05/25/16 09:54 PMSinovac Biotech, Ltd. (NASDAQ:SVA) Costs Of Goods Sold Stands At $18.425 Millions - RealistInvestor.com - Sinovac Biotech, Ltd. (NASDAQ:SVA) Costs Of Goods Sold Stands At $18.425 MillionsRealistInvestor.comFor the fiscal ended 2015-12-31, Sinovac Biotech, Ltd. (NASDAQ:SVA) comprehensive income was $8.11 millions and for the quarter ended 2015-12-31, it was $8.11 millions. Sinovac Biotech, Ltd. (NASDAQ:SVA) posted $-0.213 millions on net loss/income ...
05/20/16 05:23 AMSinovac to Host Conference Call to Report First Quarter ... - [at noodls] - BEIJING, May 20, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results ...
05/20/16 05:00 AMSinovac to Host Conference Call to Report First Quarter of 2016 Unaudited Financial Results - [PR Newswire] - BEIJING, May 20, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results ...
05/03/16 08:05 AM3 Underfollowed Infectious Disease Stocks That Deserve More Attention -
05/02/16 05:34 PMWorth Watching Stocks: Sinovac Biotech Ltd. (NASDAQ:SVA), KeyCorp. (NYSE:KEY), Capstone Turbine Corp ... - KC Register - Worth Watching Stocks: Sinovac Biotech Ltd. (NASDAQ:SVA), KeyCorp. (NYSE:KEY), Capstone Turbine Corp ...KC RegisterSinovac Biotech Ltd. (NASDAQ:SVA) was upgraded to “buy” by analysts at Zacks. They now have a USD 5.75 price target on the stock. Sinovac Biotech Ltd. (NASDAQ:SVA) belongs to Healthcare sector. Its net profit margin is -0.40% and weekly performance ...and more »
04/29/16 12:04 PMSINOVAC BIOTECH LTD Financials -
04/28/16 08:20 PMIn China's tougher drug market, minnows open back door for 'Big Pharma' -
04/27/16 07:32 AMSinovac Biotech Ltd. breached its 50 day moving average in a Bearish Manner : SVA-US : April 27, 2016 -
04/26/16 03:12 AMSinovac Files 2015 Annual Report on Form 20-F - [PR Newswire] - BEIJING, April 26, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that it has filed its 2015 Annual Report on Form 20-F ...
04/24/16 05:48 PMSinovac Biotech, Ltd. (NASDAQ:SVA) Broker Price Targets For The Coming Week - Share Trading News - Sinovac Biotech, Ltd. (NASDAQ:SVA) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Sinovac Biotech, Ltd. (NASDAQ:SVA). The latest reports which are currently in issue on Sunday 24th of April state 0 analysts have a rating of “strong buy”, 0 analysts ...
04/22/16 05:30 PMSinovac Biotech, Ltd. (NASDAQ:SVA) Updated Broker Ratings - Risers & Fallers - Sinovac Biotech, Ltd. (NASDAQ:SVA) Updated Broker RatingsRisers & FallersA number of investment brokers have recently updated their price targets on shares of Sinovac Biotech, Ltd. (NASDAQ:SVA). According to the latest broker reports outstanding on Friday 22nd of April, 0 analysts have a rating of “strong buy”, 0 analysts ...Trader's Watch List: Sinovac Biotech Ltd. (NASDAQ:SVA), The Blackstone Group L.P. (NYSE:BX), Southwestern ...Benchmark Monitorall 2 news articles »
04/21/16 05:33 PMSinovac Biotech, Ltd. (NASDAQ:SVA) Updated Broker Price Targets - Share Trading News - Sinovac Biotech, Ltd. (NASDAQ:SVA) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Sinovac Biotech, Ltd. (NASDAQ:SVA). The latest reports which are currently in issue on Thursday 21st of April state 0 analysts have a rating of “strong buy”, 0 analysts ...
04/14/16 05:32 PMSinovac Biotech (SVA) Taps Legal, Financial Advisors to Evaluate 'Going Private' Proposal - Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here. Sinovac Biotech Ltd. (Nasdaq: SVA) announced that the independent special committee of the Company's Board of Directors, formed to consider "going private" proposals ...
04/14/16 07:31 AMSinovac Biotech Special Committee Hires Financial And Legal Advisors - Benzinga - Sinovac Biotech Special Committee Hires Financial And Legal AdvisorsBenzingaSinovac Biotech Ltd. SVA disclosed that its independent special committee of its board has hired Duff & Phelps as its financial advisor to assist in the process of going private. According to the company, it has also engaged Weil, Gotshal & Manages as ...Analyst Review: Sinovac Biotech, Ltd. (NASDAQ:SVA)Risers & FallersSinovac Biotech (SVA) Taps Legal, Financial Advisors to Evaluate 'Going Private' ProposalStreetInsider.comall 3 news articles »
04/14/16 07:22 AMSinovac Biotech Special Committee Hires Financial And Legal Advisors - Sinovac Biotech Ltd. (NASDAQ: SVA) disclosed that its independent special committee of its board has hired Duff & Phelps as its financial advisor to assist in the process of going private. According to the company, it has also engaged Weil, Gotshal & Manages as its legal counsel. Sinovac Biotech said its board formed the special committee after the receipt of a non-binding "going ...Full story available on Benzinga.com
04/14/16 05:23 AMSinovac Special Committee Engages Financial and Legal Ad... - [at noodls] - BEIJING, April 14, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. ('Sinovac' or the 'Company') (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that the independent special ...
04/14/16 05:00 AMSinovac Special Committee Engages Financial and Legal Advisors - [PR Newswire] - BEIJING, April 14, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. ("Sinovac" or the "Company") (SVA), a leading provider of biopharmaceutical products in China, announced that the independent special committee of the Company's Board of Directors, formed to consider "going private" proposals received by the Company, has appointed yesterday Duff & Phelps (Duff & Phelps, LLC and Duff & Phelps Securities, LLC) as its financial advisor to assist it in this process. The special committee has also appointed Weil, Gotshal & Manges as its U.S. legal counsel, and Leslie-Ann Brissett Legal Services as its Antigua counsel. Latham & Watkins is serving as U.S. legal counsel, and Delaney Law is serving as Antigua legal counsel, to the Company.
04/11/16 07:57 AMSinovac Biotech Ltd. :SVA-US: Earnings Analysis: Q4, 2015 By the Numbers -
04/11/16 06:53 AMSinovac Biotech Ltd. :SVA-US: Earnings Analysis: 2015 By the Numbers -
04/08/16 05:36 PMAnalyst Review: Sinovac Biotech, Ltd. (NASDAQ:SVA) - Risers & Fallers - Analyst Review: Sinovac Biotech, Ltd. (NASDAQ:SVA)Risers & FallersA number of investment brokers have recently updated their price targets on shares of Sinovac Biotech, Ltd. (NASDAQ:SVA). According to the latest broker reports outstanding on Friday 8th of April, 0 analysts have a rating of “strong buy”, 0 analysts ...
04/06/16 07:49 AMFinancial Results: Sinovac Biotech Ltd. (SVA) - share market updates (press release) - share market updates (press release)Financial Results: Sinovac Biotech Ltd. (SVA)share market updates (press release)Shares of Sinovac Biotech Ltd. (NASDAQ:SVA) ended Tuesday session in red amid volatile trading. The shares closed down -0.03 points or -0.47% at $6.36 with 49,029 shares getting traded. Post opening the session at $6.35, the shares hit an intraday low ...Sinovac Biotech Ltd. (SVA) Releases Earnings ResultsThe Vista Voiceall 2 news articles »
04/05/16 05:21 PMSinovac Biotech (SVA) Up Slightly Ahead of Quarterlies - Sinovac Biotech Ltd. (NASDAQ: SVA) shares eked up 0.2% to $6.40, as the company is expected to post its quarterly earnings. Share volume was 8,700, compared to an all-day average of 152,000
04/05/16 07:42 AMEarnings Scheduled For April 5, 2016 - Benzinga - BenzingaEarnings Scheduled For April 5, 2016BenzingaSinovac Biotech Ltd. SVA is expected to post its quarterly earnings. Supercom Ltd SPCB is estimated to post its quarterly earnings at $0.15 per share on revenue of $9.03 million. Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets.and more »
04/05/16 07:42 AMEARNINGS SUMMARY: Details of Sinovac Biotech Ltd. Q4 Earnings Report - Below are the earnings highlights for Sinovac Biotech Ltd. (SVA): -Earnings: $2.18 million in Q4 vs. $2.58 million in the same period last year. -EPS: $0.03 in Q4 vs. $0.03 in the same period last year. -Revenue: $22.95 million in Q4 vs. $20.30 million in ...
04/05/16 07:41 AMSinovac posts 4Q profit - BEIJING (AP) _ Sinovac Biotech Ltd. (SVA) on Tuesday reported fourth-quarter net income of $504,000. On a per-share basis, the Beijing-based company said it had profit of 1 cent. Earnings, adjusted for non-recurring costs and stock option expense ...
04/05/16 06:28 AMSinovac Reports Unaudited Fourth Quarter and Full Year 2... - [at noodls] - BEIJING, April 5, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited fourth quarter and twelve month financial results ...
04/05/16 06:07 AMQ4 2015 Sinovac Biotech Ltd Earnings Release - Before Market Open -
04/05/16 05:16 AMSinovac Reports Unaudited Fourth Quarter and Full Year 2015 Financial Results - [PR Newswire] - BEIJING, April 5, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited fourth quarter and twelve month financial ...
04/04/16 05:25 PMLatest Analyst Ratings For Sinovac Biotech, Ltd. (NASDAQ:SVA) - Share Trading News - Latest Analyst Ratings For Sinovac Biotech, Ltd. (NASDAQ:SVA)Share Trading NewsSinovac Biotech, Ltd. has a 50 day moving average of 6.41 and a 200 day moving average of 5.65. The stock's market capitalization is 362.24M, it has a 52-week low of 4.38 and a 52-week high of 7.16. The share price of the company (NASDAQ:SVA) was up ...
04/03/16 04:56 PMCompany Shares of Sinovac Biotech Ltd. (NASDAQ:SVA) Rally 0.94% - SCSUCollegian - Company Shares of Sinovac Biotech Ltd. (NASDAQ:SVA) Rally 0.94%SCSUCollegianSinovac Biotech Ltd. (NASDAQ:SVA) has climbed 0.94% in the past week and advanced 0.31% in the last 4 weeks. The stocks are negative as compared to the S&P 500 for the past week with a loss of 0.85%. Sinovac Biotech Ltd. (NASDAQ:SVA) has ...
03/31/16 08:36 AMCurrent Price Targets For Sinovac Biotech, Ltd. (NASDAQ:SVA) - Risers & Fallers - Current Price Targets For Sinovac Biotech, Ltd. (NASDAQ:SVA)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Sinovac Biotech, Ltd. (NASDAQ:SVA). The latest broker reports which are currently outstanding on Thursday 31st of March state 0 analysts have a rating of “strong buy”, ...Sinovac Biotech Incorporated (NASDAQ:SVA) Shorts Decreased by 0.14% After Short CoveringStock Callerall 2 news articles »
03/30/16 07:57 AMSinovac Biotech Ltd. (SVA) Short Interest Disclosure - The Sussex Pilot - Sinovac Biotech Ltd. (SVA) Short Interest DisclosureThe Sussex PilotSinovac Biotech Ltd. (NASDAQ:SVA) has seen a shortfall of 602 shares or 0.1% in the short interest. The remaining shorts are 1.2% of the total floated shares. The net short interest, as on March 15,2016, stood at 427,945 shares and the stocks days to ...After Last Week What Do Analysts Think Of Sinovac Biotech, Ltd. (NASDAQ:SVA)Share Trading NewsSinovac Biotech Adopts Shareholder Rights Plan to Protect Against Hostile Takeover (NASDAQ:SVA)Sonoran Weekly ReviewSinovac Biotech Ltd.: Sinovac to Host Conference Call to Report Fourth Quarter...The Wall Street Transcriptall 7 news articles »
03/29/16 05:33 AMSinovac to Host Conference Call to Report Fourth Quarter... - [at noodls] - BEIJING, March 29, 2016 -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the fourth ...
03/29/16 05:00 AMSinovac to Host Conference Call to Report Fourth Quarter and Full Year 2015 Unaudited Financial Results - [PR Newswire] - BEIJING, March 29, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results ...
03/28/16 05:27 PMSinovac Adopts Shareholder Rights Plan and Declares Divi... - [at noodls] - BEIJING, March 28, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. ('Sinovac' or the 'Company') (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that its board of directors ...
03/28/16 05:00 PMSinovac Adopts Shareholder Rights Plan and Declares Dividend Distribution of Preferred Share Purchase Rights - [PR Newswire] - BEIJING, March 28, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that ...
03/28/16 04:54 PMAfter Last Week What Do Analysts Think Of Sinovac Biotech, Ltd. (NASDAQ:SVA) - Share Trading News - After Last Week What Do Analysts Think Of Sinovac Biotech, Ltd. (NASDAQ:SVA)Share Trading News04/15/2014 – Sinovac Biotech, Ltd. was downgraded to “hold” by analysts at TheStreet. The share price of Sinovac Biotech, Ltd. (NASDAQ:SVA) was up +0.00% during the last trading session, with a day high of 6.38. 30209 shares were traded on Sinovac ...
03/25/16 05:00 PMSinovac Biotech Incorporated (NASDAQ:SVA) Sellers Covered 18.57% of Their Shorts - RiversideGazette.com - Sinovac Biotech Incorporated (NASDAQ:SVA) Sellers Covered 18.57% of Their ShortsRiversideGazette.comThe short interest to Sinovac Biotech Incorporated's float is 1.2%. The stock decreased 0.47% or $0.03 on March 24, hitting $6.36. About 34,092 shares traded hands. Sinovac Biotech Ltd. (NASDAQ:SVA) has risen 9.84% since August 19, 2015 and is ...Sinovac Biotech, Ltd. (NASDAQ:SVA) New Analyst RatingsShare Trading Newsall 2 news articles »
03/23/16 05:03 PMLatest Analysts Reports On Sinovac Biotech, Ltd. (NASDAQ:SVA) - Risers & Fallers - Latest Analysts Reports On Sinovac Biotech, Ltd. (NASDAQ:SVA)Risers & FallersSinovac Biotech, Ltd. has a 50 day moving average of 6.44 and a 200 day moving average of 5.59. The stock's market capitalization is 361.11M, it has a 52-week low of 4.38 and a 52-week high of 7.16. The share price of the company (NASDAQ:SVA) was up ...
03/21/16 05:28 PMWatch These Hot Ones: Calix Inc. (NYSE:CALX), Sinovac Biotech (NASDAQ:SVA), UQM Technologies Inc. (NYSEMKT ... - Property Mentor - Watch These Hot Ones: Calix Inc. (NYSE:CALX), Sinovac Biotech (NASDAQ:SVA), UQM Technologies Inc. (NYSEMKT ...Property MentorSinovac Biotech Ltd. (NASDAQ:SVA) ended the last trading day at $6.39. Company weekly volatility is calculated as 1.32% and price to cash ratio as 6.56. Sinovac Biotech Ltd. (NASDAQ:SVA) showed a weekly performance of -0.47%. On 18 March, UQM ...and more »
03/21/16 08:16 AMSinovac Biotech Incorporated (NASDAQ:SVA) Shorts Decreased by 18.57% After Short Covering - Business Standard Tribune - Sinovac Biotech Incorporated (NASDAQ:SVA) Shorts Decreased by 18.57% After Short CoveringBusiness Standard TribuneWith 128,100 shares average volume, it will take short sellers 3 days to cover their SVA's short positions. The short interest to Sinovac Biotech Incorporated's float is 1.2%. The stock increased 0.63% or $0.04 on March 18, hitting $6.39. Sinovac ...
03/17/16 05:20 PMRecent Broker Updates On Sinovac Biotech, Ltd. (NASDAQ:SVA) - Risers & Fallers - Recent Broker Updates On Sinovac Biotech, Ltd. (NASDAQ:SVA)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Sinovac Biotech, Ltd. (NASDAQ:SVA). The latest broker reports which are currently outstanding on Thursday 17th of March state 0 analysts have a rating of “strong buy”, ...Sinovac Biotech Incorporated (NASDAQ:SVA) Short Interest Decreased By 18.57%RiversideGazette.comall 2 news articles »
About Sinovac Biotech

Sinovac Biotech logoSinovac Biotech Ltd. (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and H1N1 pandemic influenza and mumps, as well as animal rabies. The Company's pipeline consists of vaccine candidates in the clinical and pre-clinical development Phases in China. The Company is engaged in sales, marketing, manufacturing, and development of vaccines for infectious disease. The Company is developing products, including Healive, Bilive, Anflu, Panflu Whole Viron Pandemic Influenza Vaccine, Split Viron Pandemic Influenza Vaccine, Panflu.1, RabEnd, Mumps Vaccine, EV71 Vaccine, Pneumococcal Polysaccharide Vaccine, Varicella Vaccine, Sabin Inactivated Polio Vaccine, Hep B Vaccines, and Hep A&B Vaccine, among others.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: SVA
  • CUSIP:
Key Metrics:
  • Previous Close: $6.03
  • 50 Day Moving Average: $6.00
  • 200 Day Moving Average: $6.01
  • P/E Ratio: 143.57
  • P/E Growth: 0.00
  • Market Cap: $343.16M
  • Current Quarter EPS Consensus Estimate: $-0.05 EPS
Additional Links:
Sinovac Biotech (NASDAQ:SVA) Chart for Saturday, June, 25, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha